Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancer Chemotherapy and Pharmacology|December 22, 2011
Anti-tumor activity and mechanism of action for a cyanoaziridine-derivative, AMP423Robert T Dorr, Lee Wisner, Betty K Samulitis, et al.
Biochemical Pharmacology|December 8, 2007
Proteasomal inhibition stabilizes topoisomerase IIalpha protein and reverses resistance to the topoisomerase II poison ethonafide (AMP-53, 6-ethoxyazonafide)Lauren M Congdon, Alan Pourpak, Aluvia M Escalante, et al.
International Journal of Gastrointestinal Cancer|October 18, 2005
Induction of apoptosis and cell cycle arrest by imexon in human pancreatic cancer cell linesRobert T Dorr, Mary Ann Raymond, Terry H Landowski, et al.
Cancer Research|May 4, 2005
Mitochondrial-mediated disregulation of Ca2+ is a critical determinant of Velcade (PS-341/bortezomib) cytotoxicity in myeloma cell linesTerry H Landowski, Christina J Megli, Kevin D Nullmeyer, et al.
Molecular Cancer Therapeutics|March 6, 2008
Ellipticine derivative NSC 338258 represents a potential new antineoplastic agent for the treatment of multiple myelomaErming Tian, Terry H Landowski, Owen W Stephens, et al.
Molecular Cancer Research : MCR|January 26, 2012
Imexon induces an oxidative endoplasmic reticulum stress response in pancreatic cancer cellsElena V Sheveleva, Terry H Landowski, Betty K Samulitis, et al.
Anti-Cancer Drugs|November 20, 2002
Imexon activates an intrinsic apoptosis pathway in RPMI8226 myeloma cellsKaterina Dvorakova, Claire M Payne, Terry H Landowski, et al.
Antibodies (Basel, Switzerland)|October 24, 2022
High-Resolution Epitope Mapping and Affinity Binding Analysis Comparing a New Anti-Human LAG3 Rabbit Antibody Clone to the Commonly Used Mouse 17B4 CloneP Daniel Warren, Mark S Dodson, Margaret H Smith, et al.
Translational Oncology|June 9, 2016
Magnetic Resonance Imaging Identifies Differential Response to Pro-Oxidant Chemotherapy in a Xenograft ModelTerry H Landowski, Gerald P Guntle, Dezheng Zhao, et al.
Cancer Chemotherapy and Pharmacology|April 11, 2013
Preventing the autophagic survival response by inhibition of calpain enhances the cytotoxic activity of bortezomib in vitro and in vivoAluvia M Escalante, Ryan T McGrath, Matthew R Karolak, et al.
Pageof 3